BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18176398)

  • 1. [Anti-TNF alpha therapy: a risk factor for legionella infection].
    Lagier JC; Andriamanantena D; Damiano J; Dot JM; Chaudier B; Margery J
    Rev Mal Respir; 2007 Nov; 24(9):1159-60. PubMed ID: 18176398
    [No Abstract]   [Full Text] [Related]  

  • 2. [TNF inhibitors for treatment of rheumatoid arthritis].
    Otomo K; Koike T
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2405-12. PubMed ID: 19149036
    [No Abstract]   [Full Text] [Related]  

  • 3. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
    Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
    CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proper usage of biologics for treatment of rheumatoid arthritis].
    Murayama M
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):894-8. PubMed ID: 19469085
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
    Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
    Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
    [No Abstract]   [Full Text] [Related]  

  • 8. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
    Gaudin P
    Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-tumor necrosis factor therapies.
    Taylor PC
    Curr Opin Rheumatol; 2001 May; 13(3):164-9. PubMed ID: 11333343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.
    Hyrich KL; Silman AJ; Watson KD; Symmons DP
    Ann Rheum Dis; 2004 Dec; 63(12):1538-43. PubMed ID: 15242866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked regression of pulmonary rheumatoid nodules under etanercept therapy.
    Derot G; Marini-Portugal A; Maitre B; Claudepierre P
    J Rheumatol; 2009 Feb; 36(2):437-9. PubMed ID: 19208569
    [No Abstract]   [Full Text] [Related]  

  • 13. Etanercept and methotrexate in rheumatoid arthritis.
    Malgarini RB; Pimpinella G
    Lancet; 2004 May; 363(9422):1733; author reply 1733. PubMed ID: 15158641
    [No Abstract]   [Full Text] [Related]  

  • 14. COMET's path, and the new biologicals in rheumatoid arthritis.
    Kremer JM
    Lancet; 2008 Aug; 372(9636):347-8. PubMed ID: 18635257
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.
    Greenwald MW; Shergy WJ; Kaine JL; Sweetser MT; Gilder K; Linnik MD
    Arthritis Rheum; 2011 Mar; 63(3):622-32. PubMed ID: 21360491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxiella burnetii infection (Q fever) in rheumatoid arthritis patients with and without anti-TNFα therapy.
    Schoffelen T; Kampschreur LM; van Roeden SE; Wever PC; den Broeder AA; Nabuurs-Franssen MH; Sprong T; Joosten LA; van Riel PL; Oosterheert JJ; van Deuren M; Creemers MC
    Ann Rheum Dis; 2014 Jul; 73(7):1436-8. PubMed ID: 24794150
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
    Cohen G; Courvoisier N; Cohen JD; Zaltni S; Sany J; Combe B
    Clin Exp Rheumatol; 2005; 23(6):795-800. PubMed ID: 16396697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
    Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P;
    Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of multiple sclerosis associated with anti-TNF therapy.
    Sicotte NL; Voskuhl RR
    Neurology; 2001 Nov; 57(10):1885-8. PubMed ID: 11723281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonserious infections: should there be cause for serious concerns?
    Dao KH; Herbert M; Habal N; Cush JJ
    Rheum Dis Clin North Am; 2012 Nov; 38(4):707-25. PubMed ID: 23137578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.